The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.
Author: Christina Jewett
Advertisements
{
"slotId": "6845006044",
"unitType": "responsive",
"resize": "auto"
}FDA Panel Recommends Pulling Preterm Birth Drug From the Market